Asset Prioritization

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

Asset Prioritization Analysis to provide Strategic direction to the client in Atrial Fibrillation space along with Identification of best possible asset to support client’s future development and licensing needs.

Problem Statement:

A mid-sized pharma client was working to develop their asset portfolio and was interested in assessing best possible asset for atrial fibrillation for future development and licensing needs. The client requested evidence-based priorities in assets and products for Phase II development in atrial fibrillation, through potential licensing collaborations. Also, the client wanted to prioritise research efforts to determine the best possible asset to leverage their research portfolio.

Our Methodology:
  • Technology Assessment
  • Company Assessment
  • Commercial Assessment
  • Clinical Assessment
  • Primary Assessment
  • Matrix Analysis
  • Best Possible Asset Identified
Results:
  • Matrix Analysis positioned the top 20 companies researched.
  • The client could assess the Top companies which would effectively fit their strategic needs and objectives (the TARGET quadrant).
  • Insights into market trends for different candidates the company is developing and helping to prioritise the products.

Related Insights

In-Licensing Opportunity
In-Licensing Opportunity

A large client based in USA, involved in drug delivery devices, with effective marketing and commercialization presence across the globe, wanted to in-license potential dMTS based drug delivery asset... [...]

View Case
Out Licensing Opportunity
Out-Licensing Opportunity

A small pharmaceutical client based at Sweden, Europe with capabilities around a neonatal mesenchymal cells involved DelveInsight to identify a licensing partner for their stem cells product, from acr... [...]

View Case
Go-To-Market Strategy
Go-To-Market Strategy

A medium pharmaceutical client based in United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes and strategies to launch their biosimilar in Europe... [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.